LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
Dr. Robert Lenz brings over 20 years of experience in neuroscience drug developmentNEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --...
Neuroscience
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions
A 2026 informational consumer research report examining MagnesiumFreeze (Magnesium Niacinamide Relief) topical nerve support claims, ingredient research context, pricing disclosures,...
The world’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain
The Brain Prize 2026 is awarded to Professors David Ginty (US) and Patrik Ernfors (Sweden) for their pioneering discoveries on...
Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online
Titled "The Potential of Fasting and Diet in the Future of Medicine"Highlighting the Potential of Ketones - from Fasting, the...
Overlake Medical Center & Clinics Partners With Hyro to Modernize Patient Access Through Responsible AI
Partnership automates 51% of MyChart password resets and resolves 90% of patient digital inquiries, while laying the foundation for scalable...
Linus Health to Present New Findings on Digital Risk Scores for Dementia and Patient-Centered Endpoints at Leading Global Alzheimer’s and Parkinson’s Conference
BOSTON, March 3, 2026 /PRNewswire/ -- Linus Health will present new research at a leading global Alzheimer's and Parkinson's Diseases...
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial...
GLP-1 drugs associated with reduced need for emergency care for migraine
Drugs also related to lower use of drugs to stop, prevent attacksHighlights:For people with chronic migraine, starting GLP-1 drugs for...
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
Adds Avidity’s differentiated muscle-directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-stage programs to industry-leading neuromuscular pipelinePotentially unlocks multi-billion-dollar opportunities...
Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk
Highlights:A new review of research has found the number of parents refusing vitamin K injections for their newborns is on...
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the...
Cold Spring Harbor Laboratory neuroscientist recreates monkey vision with email-sized AI
COLD SPRING HARBOR, N.Y., Feb. 25, 2026 /PRNewswire/ -- What does it take to make AI that can pass as...
X3 Holdings Expands Into AI Healthcare Through Strategic Smartwatch Partnership
SINGAPORE, Feb. 24, 2026 /PRNewswire/ -- X3 Holdings Co., Ltd. (Nasdaq: XTKG) ("X3 Holdings" or the "Company"), a global provider...
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today...
Zyphra Releases ZUNA – BCI Foundation Model Advancing Towards Thought-to-Text
New brain-computer interface AI model improves real-world EEG data while advancing Zyphra's mission to develop human-aligned superintelligenceSAN FRANCISCO, Feb. 18,...
Jamie Weeks & Founders Row Invest in Ohm Health, Launching “Intentional Disconnection” Wellness Thesis
ATLANTA, Feb. 17, 2026 /PRNewswire/ -- Founders Row and its founder, Jamie Weeks, today announced a strategic investment and advisory partnership with...
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform...
BrainsWay Announces Change in ADS-to-Ordinary Share Ratio
Change in ADS ratio aimed at simplifying comparisons to ordinary shares traded on the Tel Aviv Stock Exchange, while boosting...
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...